| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Antitumor efficacy of wild-type p53-specific CD4(+) T-helper cells. | Cancer Res | 2002 | 0.88 |
| 2 | PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis. | Arthritis Res Ther | 2013 | 0.79 |